CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net revenues	$ 61	$ 5	$ 192	$ 19
Operating expenses
Cost of revenues	39	0	108	0
Research and development, net of settlement of trade debt of $15 for the nine months ended September 30, 2011	82	56	265	171
Selling, general and administrative, net of adjustment trade debts of $490 for the three month ended September 30, 2012	(136)	460	649	1,294
Total operating expenses	(15)	516	1,022	1,465
Operating (loss) income	76	(511)	(830)	(1,446)
Other income (expense)
Benefit from derivative liability	0	0	0	30
Interest expense related party	(59)	(45)	(170)	(124)
Interest expense	(3)	(4)	(9)	(10)
Total other income (expense)	(62)	(49)	(179)	(104)
Net (loss) income	14	(560)	(1,009)	(1,550)
Preferred stock dividend	(67)	(67)	(199)	(199)
Net loss applicable to common stockholders	$ (53)	$ (627)	$ (1,208)	$ (1,749)
Basic and diluted net loss per common share	$ 0.00	$ (0.01)	$ (0.02)	$ (0.03)
Basic and diluted weighted average number of common shares outstanding	72,964,624	59,759,909	70,278,553	55,644,245